FIELD: medicine.
SUBSTANCE: present invention relates to medicine, namely to therapy, and concerns treating osteoporosis associated with hypergastrinemia. That is ensured by administering an effective amount of YF476.
EFFECT: this provides higher density of bone tissue and bone strength due to selective inhibition of CCK2 receptors.
12 cl, 58 dwg, 15 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROPHYLAXIS AND TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND DISORDERS | 1998 |
|
RU2214236C2 |
| APPLICATION OF SOPHORICOSIDE FOR PREPARING DRUGS | 2009 |
|
RU2454236C1 |
| PROBIOTIC STRAINS FOR APPLICATION IN OSTEOPOROSIS TREATMENT OR PREVENTION | 2014 |
|
RU2636027C2 |
| COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING MENOPAUSAL SYNDROME IN FEMALES, CONTAINING LOGANIN OR DERIVATIVES THEREOF AS AN ACTIVE INGREDIENT | 2017 |
|
RU2697672C1 |
| αvβ3 SELECTIVE POLYPEPTIDE, METHOD FOR PREPARING IT, POLYNUCLEOTIDE CODING IT, COMPOSITION CONTAINING SAID PEPTIDE, AND METHOD FOR TREATING AND PREVENTING | 2007 |
|
RU2477727C2 |
| METHODS OF TREATING AND/OR SUPPRESSING WEIGHT GROWTH | 2000 |
|
RU2519642C2 |
| METHOD FOR MASS INCREASE TREATMENT AND/OR INHIBITION | 2013 |
|
RU2636498C2 |
| THERAPEUTIC AGENTS FOR REDUCTION OF PARATHYROID HORMONE LEVELS | 2010 |
|
RU2557654C2 |
| METHOD OF MASS INCREASE TREATMENT AND/OR INHIITION | 2000 |
|
RU2327461C2 |
| METHODS OF TREATING CANCER | 2016 |
|
RU2737496C2 |
